Statutory Committee meeting
The Statutory Committee will meet at the Royal Pharmaceutical Society of Great Britain, 1 Lambeth High Street, London SE1, at 9.30am on Monday 11, Tuesday 12 and Wednesday 13 December 2006 to hear the following inquiries:
1. The committee will resume the inquiry into a complaint by the Council
of the Society against Lyndon Lien Sun Wou (registration number 67470),
which alleges that the use of abusive and threatening language and behaviour
towards two assistants and the failure to deal appropriately with a patient’s
request to dispense her medication, may amount to misconduct.
2. The committee will hear the new inquiry into a complaint by the Council
of the Society against Ramanlal Ambaram Mistry (registration number 74751)
and Mistry Pharmacy Ltd (identification number 1084440), which alleges that
the dispensing to a patient of atenolol tablets, labelled as amitriptyline,
in response to a prescription calling for amitriptyline hydrochloride; dispensing
to a patient doxazosin, labelled as tolterodine, in response to a prescription
calling for tolterodine; dispensing to a patient ramipril capsules, labelled
as lisinopril tablets, in response to a prescription calling for lisinopril
tablets, causing or permitting atenolol tablets which had previously been dispensed
to be returned to dispensary stock, causing or permitting additional medicines
which had previously been dispensed to patients to be returned to dispensary
stock, and causing or permitting (through a failure to appoint a superintendent
pharmacist between 1 April 2000 and 4 July 2005) the company to carry on a
retail pharmacy business unlawfully during that period, may amount to misconduct.
3. The committee will deliver the determination of the inquiry into a complaint
by the Council of the Society against Korush Jalali Farahani (registration
number 1067185) which alleged that the theft of a number of codeine phosphate
tablets from a pharmacy while working as a locum pharmacist, the possession
of 14 Kapake capsules which had not been prescribed for him, and the consumption
of codeine phosphate tablets and Kapake capsules while working as a locum pharmacist,
may have amounted to misconduct. The committee also considered a conviction
for the theft of 40 codeine phosphate 30mg tablets and 14 zolpidem tartrate
10mg tablets of a value unknown belonging to Superdrug Plc, contrary to Sections
1(1) and 7 of the Theft Act 1968.
4. The committee will deliver the determination of the inquiry into a complaint
by the Council of the Society against Bijal Vithalbhai Patel (registration
number 84459) and Greenoaks Pharmacy Ltd (identification number 1003087), which
alleged that the submission of wrong claims to the Prescription Pricing Authority
resulting in an overpayment to the company of £16,509.67, the operation
of a system involving the alteration of endorsements on prescriptions by a
superintendent pharmacist who was not the dispensing pharmacist and without
consultation with the dispensing pharmacist, a lack of professional knowledge
in relation to prescribing for and dispensing of the contraceptive pill, the
failure to keep knowledge up to date in relation to endorsements and the Drug
Tariff, the incorrect instruction by the superintendent pharmacist to a dispensing
pharmacist employed by the company in respect of dispensing against prescriptions
for the contraceptive pill, and the dishonest and/or erroneous completion and/or
submission of untrue declarations contained in applications for inclusion on
the primary care trust’s list, individually or cumulatively may have
amounted to misconduct.
5. The committee will hear the new inquiry into the case of Cyril Clement
Daniel Siou (registration number 85068), who has been convicted of having between
22 March 2001 and 28 May 2002, in the course of a business carried on by him,
assembled medicinal products, including ephedrine hydrochloride and sildenafil
citrate, other than in accordance with a licence granted for the purposes of
s8 of the Medicines Act 1968, contrary to Section 8 of the Medicines Act 1968.
David Gomez
Secretary to the Statutory Committee |
The
Pharmaceutical Journal